176 related articles for article (PubMed ID: 25691421)
21. Haploinsufficiency for ANKRD11-flanking genes makes the difference between KBG and 16q24.3 microdeletion syndromes: 12 new cases.
Novara F; Rinaldi B; Sisodiya SM; Coppola A; Giglio S; Stanzial F; Benedicenti F; Donaldson A; Andrieux J; Stapleton R; Weber A; Reho P; van Ravenswaaij-Arts C; Kerstjens-Frederikse WS; Vermeesch JR; Devriendt K; Bacino CA; Delahaye A; Maas SM; Iolascon A; Zuffardi O
Eur J Hum Genet; 2017 Jun; 25(6):694-701. PubMed ID: 28422132
[TBL] [Abstract][Full Text] [Related]
22. 3q27.3 microdeletional syndrome: a recognisable clinical entity associating dysmorphic features, marfanoid habitus, intellectual disability and psychosis with mood disorder.
Thevenon J; Callier P; Poquet H; Bache I; Menten B; Malan V; Cavaliere ML; Girod JP; Thauvin-Robinet C; El Chehadeh S; Pinoit JM; Huet F; Verges B; Petit JM; Mosca-Boidron AL; Marle N; Mugneret F; Masurel-Paulet A; Novelli A; Tümer Z; Loeys B; Lyonnet S; Faivre L
J Med Genet; 2014 Jan; 51(1):21-7. PubMed ID: 24133203
[TBL] [Abstract][Full Text] [Related]
23. Novel MEF2C point mutations in Chinese patients with Rett (-like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation.
Wang J; Zhang Q; Chen Y; Yu S; Wu X; Bao X; Wen Y
BMC Med Genet; 2018 Oct; 19(1):191. PubMed ID: 30376817
[TBL] [Abstract][Full Text] [Related]
24. Interstitial deletion of 3p22.3p22.2 encompassing ARPP21 and CLASP2 is a potential pathogenic factor for a syndromic form of intellectual disability: a co-morbidity model with additional copy number variations in a large family.
Marangi G; Orteschi D; Milano V; Mancano G; Zollino M
Am J Med Genet A; 2013 Nov; 161A(11):2890-3. PubMed ID: 24127197
[TBL] [Abstract][Full Text] [Related]
25. 263.4 kb deletion within the TCF4 gene consistent with Pitt-Hopkins syndrome, inherited from a mosaic parent with normal phenotype.
Kousoulidou L; Tanteles G; Moutafi M; Sismani C; Patsalis PC; Anastasiadou V
Eur J Med Genet; 2013 Jun; 56(6):314-8. PubMed ID: 23528641
[TBL] [Abstract][Full Text] [Related]
26. 12q24.33 deletion: report of a patient with intellectual disability and review of the literature.
Kehrer M; Singer S; Grasshoff U; Schäferhoff K; Bonin M; Riess O; Schöning M; Tzschach A
Am J Med Genet A; 2013 Jun; 161A(6):1409-13. PubMed ID: 23613162
[TBL] [Abstract][Full Text] [Related]
27. KBG syndrome: 16q24.3 microdeletion in an Indian patient.
Srivastava P; Gambhir PS; Phadke SR
Clin Dysmorphol; 2017 Jul; 26(3):161-166. PubMed ID: 28099180
[No Abstract] [Full Text] [Related]
28. Molecular cytogenetic characterization of an interstitial deletion of chromosome 21 (21q22.13q22.3) in a patient with dysmorphic features, intellectual disability and severe generalized epilepsy.
Valetto A; Orsini A; Bertini V; Toschi B; Bonuccelli A; Simi F; Sammartino I; Taddeucci G; Simi P; Saggese G
Eur J Med Genet; 2012 May; 55(5):362-6. PubMed ID: 22548977
[TBL] [Abstract][Full Text] [Related]
29. Refinement of the deletion in 8q22.2-q22.3: the minimum deletion size at 8q22.3 related to intellectual disability and epilepsy.
Kuroda Y; Ohashi I; Saito T; Nagai J; Ida K; Naruto T; Iai M; Kurosawa K
Am J Med Genet A; 2014 Aug; 164A(8):2104-8. PubMed ID: 24801133
[TBL] [Abstract][Full Text] [Related]
30. Refining the phenotype associated with MEF2C point mutations.
Bienvenu T; Diebold B; Chelly J; Isidor B
Neurogenetics; 2013 Feb; 14(1):71-5. PubMed ID: 23001426
[TBL] [Abstract][Full Text] [Related]
31. A de novo microdeletion of ANKRD11 gene in a Korean patient with KBG syndrome.
Lim JH; Seo EJ; Kim YM; Cho HJ; Lee JO; Cheon CK; Yoo HW
Ann Lab Med; 2014 Sep; 34(5):390-4. PubMed ID: 25187894
[TBL] [Abstract][Full Text] [Related]
32. Identification of a patient with intellectual disability and de novo 3.7 Mb deletion supports the existence of a novel microdeletion syndrome in 2p14-p15.
Hancarova M; Vejvalkova S; Trkova M; Drabova J; Dleskova A; Vlckova M; Sedlacek Z
Gene; 2013 Mar; 516(1):158-61. PubMed ID: 23266801
[TBL] [Abstract][Full Text] [Related]
33. Xq22.3-q23 deletion including ACSL4 in a patient with intellectual disability.
Gazou A; Riess A; Grasshoff U; Schäferhoff K; Bonin M; Jauch A; Riess O; Tzschach A
Am J Med Genet A; 2013 Apr; 161A(4):860-4. PubMed ID: 23520119
[TBL] [Abstract][Full Text] [Related]
34. Chromosome 1q31.2q32.1 deletion in an adult male with intellectual disability, dysmorphic features and obesity.
Hyder Z; Fairclough A; Douzgou S
Clin Dysmorphol; 2019 Jul; 28(3):131-136. PubMed ID: 31045593
[TBL] [Abstract][Full Text] [Related]
35. Five patients with novel overlapping interstitial deletions in 8q22.2q22.3.
Kuechler A; Buysse K; Clayton-Smith J; Le Caignec C; David A; Engels H; Kohlhase J; Mari F; Mortier G; Renieri A; Wieczorek D
Am J Med Genet A; 2011 Aug; 155A(8):1857-64. PubMed ID: 21739578
[TBL] [Abstract][Full Text] [Related]
36. A 3p interstitial deletion in two monozygotic twin brothers and an 18-year-old man: further characterization and review.
Schwaibold EM; Zoll B; Burfeind P; Hobbiebrunken E; Wilken B; Funke R; Shoukier M
Am J Med Genet A; 2013 Oct; 161A(10):2634-40. PubMed ID: 23949945
[TBL] [Abstract][Full Text] [Related]
37. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
Zweier M; Gregor A; Zweier C; Engels H; Sticht H; Wohlleber E; Bijlsma EK; Holder SE; Zenker M; Rossier E; Grasshoff U; Johnson DS; Robertson L; Firth HV; ; Ekici AB; Reis A; Rauch A
Hum Mutat; 2010 Jun; 31(6):722-33. PubMed ID: 20513142
[TBL] [Abstract][Full Text] [Related]
38. De novo 5q14.3 translocation 121.5-kb upstream of MEF2C in a patient with severe intellectual disability and early-onset epileptic encephalopathy.
Saitsu H; Igarashi N; Kato M; Okada I; Kosho T; Shimokawa O; Sasaki Y; Nishiyama K; Tsurusaki Y; Doi H; Miyake N; Harada N; Hayasaka K; Matasumoto N
Am J Med Genet A; 2011 Nov; 155A(11):2879-84. PubMed ID: 21990267
[TBL] [Abstract][Full Text] [Related]
39. 17p13.1 microdeletion: genetic and clinical findings in a new patient with epilepsy and comparison with literature.
Giordano L; Palestra F; Giuffrida MG; Molinaro A; Iodice A; Bernardini L; La Boria P; Accorsi P; Novelli A
Am J Med Genet A; 2014 Jan; 164A(1):225-30. PubMed ID: 24501763
[TBL] [Abstract][Full Text] [Related]
40. Investigation of NRXN1 deletions: clinical and molecular characterization.
Dabell MP; Rosenfeld JA; Bader P; Escobar LF; El-Khechen D; Vallee SE; Dinulos MB; Curry C; Fisher J; Tervo R; Hannibal MC; Siefkas K; Wyatt PR; Hughes L; Smith R; Ellingwood S; Lacassie Y; Stroud T; Farrell SA; Sanchez-Lara PA; Randolph LM; Niyazov D; Stevens CA; Schoonveld C; Skidmore D; MacKay S; Miles JH; Moodley M; Huillet A; Neill NJ; Ellison JW; Ballif BC; Shaffer LG
Am J Med Genet A; 2013 Apr; 161A(4):717-31. PubMed ID: 23495017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
